ACCENDRA HEALTH INC/VA/ ACH
Last close
1.21
2026-09-04
Market cap
$93.1M
2026-06-30 share count
52-week range
0.93 - 4.69
Valuation FY2025 figures against the last close
P/S0.0x
P/E—
P/FCF—
EV/EBITDA0.3x
Dividend yield—
Diluted EPS-14.31
Annual financial statements
Income statement
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.76B | $2.68B | $2.55B | $9.96B | $9.79B | $8.48B | $9.21B | $9.42B | $9.32B | $9.72B |
| Cost of revenue | $1.47B | $1.40B | $1.34B | $8.13B | $8.27B | $7.20B | $8.08B | $8.35B | $8.15B | $8.54B |
| Gross profit | $1.29B | $2.22B | $2.13B | $1.83B | $1.51B | $1.28B | $1.13B | $1.07B | $1.17B | $1.19B |
| R&D | — | $13.0M | $13.0M | $12.0M | $12.1M | — | — | — | — | — |
| SG&A | $1.07B | $1.08B | $1.00B | $1.55B | $1.08B | $1.04B | $1.02B | $952.9M | $1.02B | $970.4M |
| Operating income | $27.5M | -$217.7M | $133.2M | $142.9M | $368.5M | $204.1M | $73.2M | -$352.3M | $89.3M | $199.6M |
| Interest expense | $107.2M | $107.6M | $116.8M | $128.9M | $48.1M | $83.4M | $98.1M | $71.0M | $31.8M | $27.1M |
| Pre-tax income | -$102.0M | -$329.9M | $15.3M | $10.9M | $276.8M | $109.9M | -$28.7M | -$427.1M | $57.5M | $172.5M |
| Income tax | $729.0K | $20.9M | $6.4M | $11.5M | $55.2M | $21.8M | $6.1M | $32.4M | $15.3M | $63.8M |
| Net income | -$1.10B | -$362.7M | -$41.3M | $22.4M | $221.6M | $29.9M | -$62.4M | -$437.0M | $72.8M | $108.8M |
| EPS, basic | -14.31 | -4.73 | -0.54 | 0.30 | 3.05 | 0.47 | -1.03 | — | — | 1.76 |
| EPS, diluted | -14.31 | -4.73 | -0.53 | 0.29 | 2.94 | 0.47 | -1.03 | -7.28 | 1.20 | 1.76 |
| Shares, diluted (wtd. avg.) | $76.9M | $76.7M | $77.4M | $76.2M | $75.5M | $63.5M | $60.6M | — | $60.0M | $61.1M |
Balance sheet
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $282.0M | $27.6M | $243.0M | $86.2M | $72.0M | $134.5M | $84.7M | $103.4M | $104.5M | $185.5M |
| Inventory | $74.4M | $67.6M | $1.11B | $1.33B | $1.50B | $1.23B | $1.15B | $1.27B | $990.2M | $916.3M |
| Total current assets | $547.9M | $2.02B | $2.10B | $2.30B | $2.32B | $2.14B | $2.41B | $2.54B | $2.18B | $1.96B |
| Property, plant and equipment | $256.2M | $249.3M | — | — | — | — | $315.4M | $323.9M | $206.5M | $191.7M |
| Goodwill | $1.23B | $1.23B | $1.64B | $1.64B | $390.2M | $394.1M | $393.2M | $414.1M | $687.0M | $414.9M |
| Other intangibles | $136.5M | $210.1M | $361.8M | $445.0M | $209.7M | $243.4M | $285.0M | $314.2M | $184.5M | $82.5M |
| Total assets | $2.45B | $4.66B | $5.09B | $5.39B | $3.54B | $3.34B | $3.64B | $3.77B | $3.38B | $2.72B |
| Accounts payable | $363.6M | $359.9M | $1.17B | $1.15B | $1.00B | $1.00B | $808.0M | $1.07B | $947.6M | $750.8M |
| Short-term debt | $250.0M | $42.9M | $206.9M | $17.9M | — | $39.9M | $51.2M | $28.7M | $16.6M | $4.8M |
| Total current liabilities | $947.1M | $1.85B | $1.89B | $1.57B | $1.34B | $1.35B | $1.42B | $1.47B | $1.31B | $1.03B |
| Long-term debt | — | — | — | — | — | $986.0M | $1.51B | $1.65B | $900.7M | $564.6M |
| Total liabilities | $2.91B | $4.07B | $4.17B | $4.44B | $2.60B | $2.62B | $3.18B | $3.26B | $2.36B | $1.76B |
| Retained earnings | -$1.08B | $27.2M | $368.7M | $410.0M | $387.6M | $167.0M | $137.8M | $200.7M | $690.7M | $685.5M |
| Total equity | -$461.0M | $586.4M | $945.3M | $966.7M | $938.5M | $712.1M | $462.2M | $518.4M | $1.02B | $960.0M |
Cash flow
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$101.8M | $161.5M | $740.7M | $325.0M | $124.2M | $339.2M | $166.1M | $115.6M | $56.8M | $187.7M |
| Depreciation and amortisation | $214.5M | $181.3M | $210.4M | $228.7M | $90.6M | $93.3M | $116.7M | $101.9M | $59.4M | $55.4M |
| Stock-based compensation | $12.9M | $16.6M | $14.4M | $21.0M | $25.0M | $20.0M | $15.8M | $16.4M | $11.9M | $12.0M |
| Capital expenditure | $191.0M | $170.3M | $172.4M | $158.1M | $41.0M | $50.4M | $42.4M | $44.9M | $34.6M | $20.3M |
| Investing cash flow | $144.4M | -$116.5M | -$137.3M | -$1.80B | -$53.6M | $80.1M | -$51.9M | -$815.8M | -$416.6M | -$24.7M |
| Financing cash flow | $188.1M | -$267.6M | -$417.3M | $1.50B | -$129.5M | -$379.4M | -$130.2M | $701.1M | $272.8M | -$142.7M |
| Dividends paid | — | — | $0 | $0 | $731.0K | $648.0K | $5.2M | $48.2M | $63.2M | $63.4M |
| Buybacks | $10.2M | — | — | — | — | — | — | $0 | $5.0M | $71.0M |
Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001104659-26-018169.
Others in SIC 5047
| Ticker | Company | Market cap | P/E | Revenue growth |
|---|---|---|---|---|
| HSIC | HENRY SCHEIN INC | $10.01B | 27.5x | 4.0% |